Australian biotech CSL announces $1.5B investment in the U.S.
Source: SeekingAlpha
2025-11-18 10:59:06 ET
More on CSL
- CSL Limited (CSLLY) Analyst/Investor Day Prepared Remarks Transcript
- CSL Limited (CSLLY) Shareholder/Analyst Call Transcript
- CSL Limited (CSLLY) Shareholder/Analyst Call - Slideshow
- Seeking Alpha’s Quant Rating on CSL
- Historical earnings data for CSL
Read the full article on Seeking Alpha
For further details see:
Australian biotech CSL announces $1.5B investment in the U.S.
CSL Ltd. ADR
NASDAQ: CSLLY
CSLLY Trading
-1.94% G/L:
$24.75 Last:
372,157 Volume:
$24.91 Open:
CSLLY Latest News
March 09, 2026 11:01:00 am
CSL announces expansion of Illinois plasma therapy manufacturing facility
March 06, 2026 09:00:00 am
Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract
January 27, 2026 02:06:00 pm
Deutsche Bank Appointed as Successor Depositary Bank for the American Depositary Receipt Program of CSL Limited
CSLLY Stock Data
$59,010,931,430
958,728,992
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
AU
Prakville Victoria Austra
